ABG
KURA icon

Ally Bridge Group’s Kura Oncology KURA Stock Holding History

Ally Bridge Group’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.18M Buy
+290,000
New +$2.74M 2.81% 11
2024
Q4 		– Sell
-294,081
Closed -$5.75M – 34
2024
Q3 		$5.75M Sell
294,081
-12,681
-4% -$257K 3.08% 16
2024
Q2 		$6.32M Sell
306,762
-58,282
-16% -$1.2M 3.76% 14
2024
Q1 		$7.79M Buy
+365,044
New +$7.1M 4.33% 12

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Ally Bridge Group's KURA Position: Q2 2026 in Review

Ally Bridge Group opened a new position in Kura Oncology (KURA) in Q2 2026: 290,000 shares worth $3.18M. The stake represents 2.81% of the portfolio and ranks #11 among its holdings. This is a return to the name: Ally Bridge Group previously reported a position in KURA as recently as Q3 2024.

Ally Bridge Group first reported a position in KURA in Q1 2024 and has held it in 4 quarters since. The position peaked at $7.79M in Q1 2024. 221 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Ally Bridge Group held 290,000 shares of Kura Oncology worth $3.18M as of Q2 2026.
  • Kura Oncology was a new Ally Bridge Group position in Q2 2026.
  • Kura Oncology made up 2.81% of Ally Bridge Group's portfolio in Q2 2026, its #11 holding.
  • Ally Bridge Group first reported a position in Kura Oncology in Q1 2024 and has held it in 4 quarters since.
  • Ally Bridge Group's Kura Oncology position peaked at $7.79M in Q1 2024.
  • 221 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Ally Bridge Group's 13F filing for Q2 2026, filed 14 Aug 2026.